These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37404754)
1. Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics. Gu L; Ding D; Wei C; Zhou D Front Oncol; 2023; 13():1158863. PubMed ID: 37404754 [TBL] [Abstract][Full Text] [Related]
2. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Zheng H; Liu H; Li H; Dou W; Wang X Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770 [No Abstract] [Full Text] [Related]
3. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis. Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY Front Oncol; 2023; 13():1191660. PubMed ID: 37207166 [TBL] [Abstract][Full Text] [Related]
4. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer. Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C Front Immunol; 2022; 13():951214. PubMed ID: 35967313 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of cancer-associated fibroblast signature in gastric cancer. Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer. Zhang J; Zhang N; Fu X; Wang W; Liu H; McKay MJ; Dejkriengkraikul P; Nie Y Ann Transl Med; 2022 Jun; 10(12):698. PubMed ID: 35845527 [TBL] [Abstract][Full Text] [Related]
7. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer. Liu W; Wang M; Wang M; Liu M Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing. Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799 [TBL] [Abstract][Full Text] [Related]
9. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
10. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y Front Immunol; 2023; 14():1199040. PubMed ID: 37313409 [TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer. Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H Front Immunol; 2022; 13():956224. PubMed ID: 36032075 [TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204 [No Abstract] [Full Text] [Related]
13. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC. Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma. Dong W; Xie Y; Huang H Front Endocrinol (Lausanne); 2022; 13():884777. PubMed ID: 35733776 [TBL] [Abstract][Full Text] [Related]
15. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447 [TBL] [Abstract][Full Text] [Related]
16. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Zheng H; Liu H; Ge Y; Wang X Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584 [TBL] [Abstract][Full Text] [Related]
17. Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production. Xia Y; Wang X; Lin J; Li Y; Dong L; Liang X; Wang HY; Ding X; Wang Q Front Immunol; 2024; 15():1375013. PubMed ID: 39040110 [TBL] [Abstract][Full Text] [Related]
18. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma. Cen X; Li M; Yao A; Zheng Y; Lai W J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069 [TBL] [Abstract][Full Text] [Related]
19. Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma. Gu Y; Zhuo H Aging Male; 2023 Dec; 26(1):2233609. PubMed ID: 37428096 [TBL] [Abstract][Full Text] [Related]
20. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1 Jia X; Li Z; Zhou R; Feng W; Yi L; Zhang H; Chen B; Li Q; Huang S; Zhu X Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167123. PubMed ID: 38484940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]